Longevity research network, Rejuve.AI, today launches Rejuve Longevity, an app that combines AI, cutting-edge research and blockchain technology to widen access to longevity treatments and advice. Rejuve Longevity analyzes users’ demographic, medical, and lifestyle data to give them a biological age estimate, alongside other personalized health insights. At its core, Rejuve Longevity is designed to help its users understand how to extend their healthy lifespans while putting power back into the hands of its users by ensuring they receive a fair share of proceeds gained from the use of their data.
The data on which insight is built is gathered using demographic, medical, and lifestyle data from wearables or self-inputted by the user. Users then have the option to opt-in to studies and databases, being paid for participation using Rejuve.AI’s RJV crypto token, which can be used in-app to purchase products such as supplements and DNA tests. The app is designed to not only help users maximise their health, but also provide a deeper dive into data concerning lifespan. The app enables users to plunge into cutting-edge rejuvenation therapies as they come onboard, alongside a range of AI insights.
Rejuve Longevity calculates longevity recommendations using over 370 biomarkers, with over 300 present in the AI, one of the largest sets available in today’s market. Alongside this, the app’s systems are built on Bayes Expert, Rejuve.AI’s revolutionary approach to integrating diverse scientific studies into a holistic understanding of health risks and intervention. Rejuve.AI’s cutting-edge attitude to the intersection between technology and health makes today’s app launch an exciting development for the health technology community.
Jasmine Smith, Chief Executive Officer of Rejuve.AI, said: “The Longevity app is one-of-a-kind. While other wellbeing apps monitor one or a few aspects of a person’s health, Rejuve Longevity allows users to earn, discover trusted products and providers, and eventually combine various data types such as genetics, epigenetics and telomeres to get a truly holistic view of their health and longevity progress. It also, crucially, allows individuals to take back control of, and benefit from their personal data.
“The level and speed of progress being made in the longevity space is astounding. But that progress shouldn’t be gatekept. Anyone who wants to live a healthier, longer life should have the tools and insight to do so. This is the mission on which we founded Rejuve, and it’s so exciting to see this come to life two years after we penned the initial whitepaper.”
Dr Ben Goertzel, Chief AI Scientist at Rejuve.AI and CEO of SingularityNET, is just one of the AI leaders who has contributed to the app’s development, as well as Chief Technology Officer Dr Deborah Duong, an industry leader in AGI research. This expertise, paired with the app’s presence within the SingularityNET ecosystem (part of the ASI Alliance), means that the app is built on first-class technology.
Goertzel commented: “AI is advancing with remarkable speed, as is the accumulation of valuable biomedical data. There seems little doubt that the application of advanced AI to all this data has tremendous potential to move forward the science of longevity toward deeper understanding and toward powerful therapies for extending human healthspan. The pharmaceutical establishment is being distressingly slow at actualizing this potential. Their business models and ways of thinking are stuck in a previous era, focused on siloing data and insights in proprietary vaults and attacking one disease at a time in isolation and in a generic way, rather than approaching health in a holistic and personal fashion. Rejuve.AI has the modest mission of solving all this, by rolling out the world’s most advanced AI and systems biology modeling technology on decentralized networks leveraging crowdsourced biomedical data, and applying these tools to the reduction and eventual elimination of involuntary human death. It’s a complex and intensive job but someone’s got to do it, our lives are very literally at stake!”
Alongside developing Rejuve Longevity, Rejuve.AI has been building a network of best-in-class partners, spanning supplements, wearables, testing, DNA sequencing, and epigenetics. This includes companies like Garmin, Travala, TruDiagnostics, Glycanage, Lifelength and AVEA. This all happened while carrying out a 4,000-person beta test of the app to ensure the app was ready for launch.
The app is launching both on Android and iOS. The app is free to download, with premium services available by subscription, which is set to arrive later this year. Users can sign up here for Android and here for IOS devices.
About Rejuve.AI
Rejuve.AI, the world’s first decentralized AI longevity research network, brings together blockchain, artificial intelligence, and cutting-edge longevity research. With a firm belief that an enhanced, healthy lifespan shouldn’t be an elite privilege, Rejuve.AI promotes equitable access to longevity benefits.
Users contribute health data via the Longevity app on iOS and Android, earning RJV tokens in return. These tokens unlock a wealth of wellness products and personalized longevity insights.
Central to Rejuve.AI is its unique tokenomic model, encompassing both the RJV utility token and innovative non-fungible tokens (NFTs) – the Data NFT (dNFT) and the Product NFT (pNFT). This structure guarantees a fair reward system for all contributors.
Beyond its platform, Rejuve.AI is carving out strategic partnerships across the longevity ecosystem, from supplement providers to biopharma companies, amplifying its impact.
In essence, Rejuve.AI isn’t just a platform—it’s a movement. Merging the technological promise of Web3 with the age-old quest for longevity, Rejuve.AI envisions a world where healthy aging is democratically accessible to all.
